IDEA Bio-Medical presents a revolutionary technological platform for the drug discovery industry.
Accelerate to discover
Related topics
Recent publication of in-vivo two-photon intravital imaging study targeting mouse kidney
May 22, 2023
In vivo longitudinal 920 nm two-photon intravital kidney imaging of a dynamic 2,8-DHA crystal
formation and...
Webinar: Multimodal tissue imaging and machine learning to advance precision medicine
May 17, 2023
Join us for this webinar to learn how the Orion spatial biology imaging platform was used to identify prognostic...
May 5, 2023
Decision to improve the output in a lab is always taken based on knowledge and workflow needs. But final decision to...
Real-Time and Quantitative Analysis of Macrophage Phagocytosis with RTCA eSight
May 4, 2023
The eSight is currently the only instrument that interrogates cell health and behavior using cellular
impedance...
A deep learning and Monte Carlo based framework for bioluminescence imaging center Maastro
Apr 20, 2023
"In this paper,we developed a framework using deep learning for bioluminescence-based targeting for GBM animal...
Gentle sorting of microbial cells and sub-micron particles using WOLF sorter
Apr 18, 2023
While most modern applications of flow cytometry may focus on cells of eukaryotic origin, the first flow analyzers were...
SPECT imaging properties of the CdTe-Timepix3 detector used in a new prototype
Apr 5, 2023
SPECT (Single Photon Emission Computed Tomography imaging) is one of the most important and widely used methods for the...
Feb 29, 2016
The Hermes WiScan imaging system provides a built-in solution for simultaneous imaging. It features image acquisition in four separate imaging channels, which can be operated in parallel or sequentially, according to the user’s requirements. This configuration allows for simultaneous measurements in live cell experiments on the one hand, and for extremely rapid scanning rates on the other hand. Successful acquisition of several fluorescence images with different wavelengths simultaneously depends on adequate experimental design, in which fluorophores are spectrally separated in order to avoid (or at least minimise) spectral bleed-through, which otherwise occur as a result of overlap between the emission spectra of probes. The Hermes WiScan® system offers a variety of optional fluorophore combinations for simultaneous acquisition to choose from, according to specific research
requirements.
Related technologies: Automated microscopy and image analysis
Brand profile
IDEA Bio-Medical presents a revolutionary technological platform for the drug discovery industry.
More info at:
www.idea-bio.com